Cargando…

Promising Neuroimaging Biomarkers in Depression

The neuroimaging has been applied in the study of pathophysiology in major depressive disorder (MDD). In this review article, several kinds of methodologies of neuroimaging would be discussed to summarize the promising biomarkers in MDD. For the magnetic resonance imaging (MRI) and magnetoencephalog...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lai, Chien-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761793/ https://www.ncbi.nlm.nih.gov/pubmed/31550875 http://dx.doi.org/10.30773/pi.2019.07.25.2

Ejemplares similares

Neuroimaging-Based Brain Age Estimation: A Promising Personalized Biomarker in Neuropsychiatry
por: Sone, Daichi, et al.
Publicado: (2022)

Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders
por: Lai, Chien-Han, et al.
Publicado: (2021)

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
por: Shi, Yachen, et al.
Publicado: (2021)

Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014)

Translational Functional Neuroimaging in the Explanation of Depression
por: Stoyanov, Drozdstoy, et al.
Publicado: (2017)

Neuroimaging Advances for Depression
por: Dunlop, Boadie W., et al.
Publicado: (2017)

Diagnostic and therapeutic utility of neuroimaging in depression: an overview
por: Wise, Toby, et al.
Publicado: (2014)

Personalized Diagnosis and Treatment for Neuroimaging in Depressive Disorders
por: Lee, Jongha, et al.
Publicado: (2022)

Neurosteroids and Neurotrophic Factors: What Is Their Promise as Biomarkers for Major Depression and PTSD?
por: Almeida, Felipe Borges, et al.
Publicado: (2021)

Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy
por: Reddy, Sandesh D., et al.
Publicado: (2019)

Neuroimaging Biomarkers in SCA2 Gene Carriers
por: Mascalchi, Mario, et al.
Publicado: (2020)

Neuroimaging studies of depressive disorders in China since 2000
por: YIN, Yingying, et al.
Publicado: (2014)

EEG/ERP as a pragmatic method to expand the reach of infant-toddler neuroimaging in HBCD: Promises and challenges
por: Norton, Elizabeth S., et al.
Publicado: (2021)

The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis
por: Haarsma, J., et al.
Publicado: (2022)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
por: van Eimeren, Thilo, et al.
Publicado: (2019)

Neuroimaging study of electroconvulsive therapy for depression
por: Chen, Xiaolu, et al.
Publicado: (2023)

Contribution of neuroimaging in late-life depression
por: Desmidt, T.
Publicado: (2023)

Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies
por: Wen, M.‐C., et al.
Publicado: (2016)

Guidelines for the conduct of clinical trials in spinal cord injury: Neuroimaging biomarkers
por: Seif, Maryam, et al.
Publicado: (2019)

Immunological and neuroimaging biomarkers of complicated grief
por: O'Connor, Mary-Frances
Publicado: (2012)

Neuroimaging to Investigate Multisystem Involvement and Provide Biomarkers in Amyotrophic Lateral Sclerosis
por: Pradat, Pierre-François, et al.
Publicado: (2014)

Brain-based Sex Differences in Depression: A Systematic Review of Neuroimaging Studies
por: Mohammadi, Soheil, et al.
Publicado: (2023)

Acylcarnitines in Ophthalmology: Promising Emerging Biomarkers
por: Theodoridis, Konstantinos, et al.
Publicado: (2022)

MR Neuroimaging in Pediatric Inborn Errors of Metabolism
por: Lai, Lillian M., et al.
Publicado: (2022)

Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
por: Agarwal, Deevyankar, et al.
Publicado: (2021)

Neuroimaging biomarkers to associate obesity and negative emotions
por: Park, Bo-yong, et al.
Publicado: (2017)

Neuroimaging Correlates of Depression—Implications to Clinical Practice
por: Castanheira, Lígia, et al.
Publicado: (2019)

Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack()
por: Atluri, Gowtham, et al.
Publicado: (2013)

CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
por: Brisson, Mélanie, et al.
Publicado: (2021)

Neuroimaging in epilepsy
por: Bano, Shahina, et al.
Publicado: (2011)

Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
por: Kuburi, Sarah, et al.
Publicado: (2022)

When change is the only constant: The promise of longitudinal neuroimaging in understanding social anxiety disorder
por: Haller, Simone P.W., et al.
Publicado: (2018)

Identifying neuroimaging biomarkers of major depressive disorder from cortical hemodynamic responses using machine learning approaches
por: Li, Zhifei, et al.
Publicado: (2022)

Neuroimaging, Biomarkers, and Management of Dementia with Lewy Bodies
por: Hanagasi, Hasmet A., et al.
Publicado: (2013)

Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases
por: Shimizu, Soichiro, et al.
Publicado: (2018)

Neuroimaging-derived brain-age: an ageing biomarker?
por: Cole, James H.
Publicado: (2017)

Dynamic Neuroimaging Biomarkers of Smoking in Young Smokers
por: Xue, Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vv0o1t3270jadlekaket385ee8